Patent applications published 2 March 2011
Selected patent applications from the weekly European Patents Bulletin
- Microencapsulation process for producing microcapsules comprising a surface-modified particulate inorganic material in a cross-linked microcapsule wall
Syngenta 2288257*
- Inhibition of neovascularisation by cerium nanoparticles
The Board of Regents of the University of Oklahoma; University of Florida Central Research Foundation 2288258*
- Stabilised, antimicrobially effective compsn with a content of bispyridinium alkane
Air Liquide Santé (international) 2288259*
- Triazolopyridine JAK inhibitor compounds and methods
Genentech 2288260*
- Polymeric systems containing intracellular releasable disulphide linker for the delivery of oligonucleotides
Enzon Pharmaceuticals 2288261*
- Prostaglandin based compsns and method of use thereof
Peter Thomas Roth Labs 2288333*
- Compsn and method for transmucosal delivery of lofexidine
US Worldmeds 2288334*
- Process for preparing orally administered dabiagatran formulations
Boehringer Ingelheim International 2288335*
- Nanostructures suitable for sequestering cholesterol
North Western University 2288336*
- Parenteral supplement with trace elements for treatment of I. A. sirs, burns and selenium deficiencies
University of Lausanne 2288337*
- Stable pharmaceutical formulations
Baxter International; Baxter Healthcare 2288338*
- In situ gelling systems as sustained delivery for front of eye
Novartis 2288339*
- Nanoparticle formulations and uses thereof
Abraxis Bioscience 2288340*
- Use of a matrix for orally administering sustained release magnesium, and compsn containing said matrix
Joanny, Fabienne 2288341*
- Magnesium system and use thereof in the cosmetics industry
Joanny, Fabienne 2288342*
- Nitric oxide-releasing compsns, devices and methods
3M Innovative Properties 2288343*
- A transdermal drug delivery device
The Secretary of State for Defence 2288344*
- Psycho-pharmaceuticals
University College Dublin, National University of Ireland 2288345*
- Oral compsns containing enhanced antibacterial combinations of antioxidants and extracts of magnolia
WM Wrigley Jr Company 2288346*
- Use of enantiomer (1S, 2R) of milnacipran hydrochloride for the preventative treatment of suicidal behaviour in depressed patients
Pierre Fabre Medicament 2288347*
- Nanoparticles functionalised with sulphated amino alcohols for the inhibition of selectin-mediated cell adhesion
Freie Universität Berlin; Charité-Universitätsmedizin Berlin 2288348*
- Therapy regimen for treating acne-relate diseases
Galderma Research & Development 2288349*
- Method of treatment with potentised stereoisomer of glutamate
Sempach 2288350*
- Novel pyrrolidone derivatives for use as metap-2 inhibitors
Merck Patent 2288351*
- Clonidone formulation in a poly-orthoester carrier
Medtronic 2288352*
- Method for treating acute pain with a formulated drug depot in combination with a liquid formulation
Warsaw Orthopaedic; Medtronic 2288353*
- Substituted benzimidazoles for neurofibromatosis
Novartis 2288354*
- Method and compsn for skin inflammation and discoloration
Fairfield Clinical Trials 2288355*
- Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation
Clasado 2288356*
- Compsns comprising red microalgae polysaccharides and metals
Ben-Gurion University of the Negev Research and Development Authority 2288357*
- Method of isolating biomacromolecules using polyalkylene glycol and transition metals
Biogen Idec 2288358*
- Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
Tissue Regeneration Therapeutics 2288359*
- Isolated lactobacillus planartum strain inducia DSM 21379 as probiotic that enhances natural immunity and food products and medicinal preparations comprising it
Oü Tervisliku Piima Biotechnoloogiate Arenduskeskus 2288360*
- Cistus extract containing enriched secondary plant ingredients
Finzelberg 2288361*
- Herbal compsn for reducing ADD/ADHD and method thereof
Nisarga Biotech 2288362*
- Plant extract and its therapeutic use
Insignion Holdings 2288363*
- Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances
Brandeis University; Malaysian Palm Oil Board 2288264*
- Targeted coagulation factors and method of using the same
Bayer Healthcare 2288365*
- Method of treating chronic heart failure
Corthera 2288366*
- Method of preventing premature delivery
Corthera 2288367*
- Compsns of peptides and processes of preparation thereof
Merrion Research III 2288368*
- Compsns of GNRH related compounds and processes of preparation
Merrion Research III 2288369*
- Osteogenic compsn including a complex growth factor/amphiphilic polymer, a soluble cation salt, and an organic substrate
Adocia 2288370*
- Osteogenic compsn including a complex growth factor/amphiphilic polymer, a soluble cation salt, and an organic substrate
Adocia 2288371*
- Means for the treatment and/or prophylaxis of an autoimmune disease and for the formulation of regulatory T-cells
AiCuris 2288372*
- Treating dyspnea associated with acute heart failure with relaxin
Corthera 2288373*